US Edition
Biocon Biologics gains contract extension for Insulins supply by Malaysian MoH - Express Pharma
Summary by Express Pharma
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Biocon Biologics gains contract extension for Insulins supply by Malaysian MoH - Express Pharma
Biocon Biologics informs that the Government of Malaysia has agreed to extend the current contract period of 36 months under the existing insulin supply agreement with its subsidiary in Malaysia, Biocon, and Duopharma Marketing (DMktg), for an additional six months, effective from April 29, 2025, until October 28, 2025. Biocon Biologics has partnered with the Ministry of Health for its insulins requirements and has been serving patients in Ma…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
